HEMP & HEALTH S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4565 PLN | +3.75% |
|
+0.55% | +43.55% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1.28 | 2.898 | 14.76 | 16.36 | 7.844 | 23 |
| Enterprise Value (EV) 1 | -0.2625 | 0.7606 | 11.73 | 13.39 | 3.864 | 19.8 |
| P/E ratio | -0.12 x | 11 x | -29.5 x | -29.7 x | -4.97 x | -27.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 7.11 x | 1.43 x | 102 x | 6.49 x | 7.31 x | 84.7 x |
| EV / Revenue | -1.46 x | 0.38 x | 81.3 x | 5.31 x | 3.6 x | 72.9 x |
| EV / EBITDA | 1.46 x | -3.1 x | -15.4 x | - | - | -28.6 x |
| EV / FCF | -0.89 x | -0.86 x | -94.3 x | -26 x | 15.2 x | -49.5 x |
| FCF Yield | -113% | -116% | -1.06% | -3.85% | 6.56% | -2.02% |
| Price to Book | 0.75 x | 0.95 x | 4.23 x | 4.15 x | 3.34 x | 6.6 x |
| Nbr of stocks (in thousands) | 16,000 | 26,350 | 29,220 | 29,220 | 39,220 | 72,313 |
| Reference price 2 | 0.0800 | 0.1100 | 0.5050 | 0.5600 | 0.2000 | 0.3180 |
| Announcement Date | 6/1/20 | 6/1/20 | 5/31/21 | 5/31/22 | 5/24/23 | 5/31/24 |
1PLN in Million2PLN
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.1801 | 2.022 | 0.1442 | 2.521 | 1.073 | 0.2715 |
| EBITDA 1 | -0.1802 | -0.2454 | -0.7619 | - | - | -0.6917 |
| EBIT 1 | -0.3164 | -0.3095 | -0.826 | -0.0106 | -0.5501 | -0.7276 |
| Operating Margin | -175.66% | -15.3% | -572.71% | -0.42% | -51.28% | -267.98% |
| Earnings before Tax (EBT) 1 | -10.34 | 0.2931 | -0.4996 | -0.5517 | -2.911 | -0.8432 |
| Net income 1 | -10.29 | 0.2931 | -0.4996 | -0.5517 | -2.911 | -0.8432 |
| Net margin | -5,711.76% | 14.49% | -346.4% | -21.89% | -271.33% | -310.56% |
| EPS 2 | -0.6430 | 0.0100 | -0.0171 | -0.0189 | -0.0403 | -0.0117 |
| Free Cash Flow 1 | 0.2961 | -0.8803 | -0.1244 | -0.5151 | 0.2534 | -0.3998 |
| FCF margin | 164.37% | -43.53% | -86.27% | -20.44% | 23.62% | -147.27% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/1/20 | 6/1/20 | 5/31/21 | 5/31/22 | 5/24/23 | 5/31/24 |
1PLN in Million2PLN
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 1.54 | 2.14 | 3.02 | 2.97 | 3.98 | 3.19 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 0.3 | -0.88 | -0.12 | -0.52 | 0.25 | -0.4 |
| ROE (net income / shareholders' equity) | -177% | 12.3% | -15.3% | -14.9% | -70.4% | -21.6% |
| ROA (Net income/ Total Assets) | -1.39% | -5.39% | -11.7% | -0.16% | -7.57% | -11.3% |
| Assets 1 | 738.1 | -5.44 | 4.268 | 339.9 | 38.45 | 7.466 |
| Book Value Per Share 2 | 0.1100 | 0.1200 | 0.1200 | 0.1300 | 0.0600 | 0.0500 |
| Cash Flow per Share 2 | 0 | 0 | 0.0100 | 0.0100 | 0.0300 | 0.0100 |
| Capex | - | - | - | - | - | 0.2 |
| Capex / Sales | - | - | - | - | - | 72.23% |
| Announcement Date | 6/1/20 | 6/1/20 | 5/31/21 | 5/31/22 | 5/24/23 | 5/31/24 |
1PLN in Million2PLN
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- HMP Stock
- Financials Hemp & Health S.A.
